GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 81 filers reported holding GLYCOMIMETICS INC in Q2 2019. The put-call ratio across all filers is 145.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,566 | -13.8% | 1,044 | 0.0% | 0.00% | – |
| Q2 2023 | $1,816 | -99.0% | 1,044 | -98.3% | 0.00% | – |
| Q1 2021 | $183,000 | -19.7% | 60,730 | 0.0% | 0.00% | – |
| Q4 2020 | $228,000 | +40.7% | 60,730 | +15.0% | 0.00% | – |
| Q3 2020 | $162,000 | -26.7% | 52,831 | -10.3% | 0.00% | – |
| Q2 2020 | $221,000 | +118.8% | 58,881 | +33.2% | 0.00% | – |
| Q1 2020 | $101,000 | -56.8% | 44,200 | 0.0% | 0.00% | – |
| Q4 2019 | $234,000 | +23.8% | 44,200 | +0.6% | 0.00% | – |
| Q3 2019 | $189,000 | -64.2% | 43,941 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $528,000 | -2.2% | 44,266 | +2.2% | 0.00% | 0.0% |
| Q1 2019 | $540,000 | +28.0% | 43,318 | -2.8% | 0.00% | 0.0% |
| Q4 2018 | $422,000 | -3.0% | 44,560 | +47.4% | 0.00% | 0.0% |
| Q3 2018 | $435,000 | -15.7% | 30,224 | -5.5% | 0.00% | 0.0% |
| Q2 2018 | $516,000 | – | 31,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,000,000 | $5,220,000 | 0.73% |
| NEA Management Company, LLC | 4,764,440 | $8,290,126 | 0.63% |
| Artal Group S.A. | 8,589,064 | $14,945 | 0.46% |
| BVF INC/IL | 9,544,262 | $16,607,016 | 0.46% |
| Sargent Investment Group, LLC | 108,000 | $187,920 | 0.05% |
| Intellectus Partners, LLC | 73,475 | $127,847 | 0.04% |
| XTX Topco Ltd | 29,998 | $52,197 | 0.01% |
| AXA S.A. | 1,631,509 | $2,838,826 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,149,656 | $1,999 | 0.01% |
| TOBIAS FINANCIAL ADVISORS, INC. | 15,000 | $26,100 | 0.01% |